CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 589284-589826
Annnotations
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T77","span":{"begin":0,"end":168},"obj":"Sentence"},{"id":"T78","span":{"begin":169,"end":402},"obj":"Sentence"},{"id":"T79","span":{"begin":403,"end":542},"obj":"Sentence"}],"text":"Besides, doxycycline therapy showed non-inferior to metronidazole or vancomycin therapy, according to body weight loss in mice with CDAD (doxycycline vs. metronidazole: 1.11 ± 0.56 kg vs. Hospital Center \"Mother Theresa\", Service of Infectious Diseases, 3 University Hospital Center \"Mother Theresa\", Service of Reanimation and Anesthesia, 4 University Hospital Center \"Mother Theresa\", SID Background: Although Tetanus is currently a relatively rare infectious disease it remains a high mortality disease (20-30%) with high management costs."}
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T44316","span":{"begin":0,"end":168},"obj":"Sentence"},{"id":"T31667","span":{"begin":169,"end":402},"obj":"Sentence"},{"id":"T7770","span":{"begin":403,"end":542},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Besides, doxycycline therapy showed non-inferior to metronidazole or vancomycin therapy, according to body weight loss in mice with CDAD (doxycycline vs. metronidazole: 1.11 ± 0.56 kg vs. Hospital Center \"Mother Theresa\", Service of Infectious Diseases, 3 University Hospital Center \"Mother Theresa\", Service of Reanimation and Anesthesia, 4 University Hospital Center \"Mother Theresa\", SID Background: Although Tetanus is currently a relatively rare infectious disease it remains a high mortality disease (20-30%) with high management costs."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T974","span":{"begin":0,"end":542},"obj":"Epistemic_statement"}],"text":"Besides, doxycycline therapy showed non-inferior to metronidazole or vancomycin therapy, according to body weight loss in mice with CDAD (doxycycline vs. metronidazole: 1.11 ± 0.56 kg vs. Hospital Center \"Mother Theresa\", Service of Infectious Diseases, 3 University Hospital Center \"Mother Theresa\", Service of Reanimation and Anesthesia, 4 University Hospital Center \"Mother Theresa\", SID Background: Although Tetanus is currently a relatively rare infectious disease it remains a high mortality disease (20-30%) with high management costs."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T1359","span":{"begin":107,"end":118},"obj":"Phenotype"}],"attributes":[{"id":"A1359","pred":"hp_id","subj":"T1359","obj":"http://purl.obolibrary.org/obo/HP_0001824"}],"text":"Besides, doxycycline therapy showed non-inferior to metronidazole or vancomycin therapy, according to body weight loss in mice with CDAD (doxycycline vs. metronidazole: 1.11 ± 0.56 kg vs. Hospital Center \"Mother Theresa\", Service of Infectious Diseases, 3 University Hospital Center \"Mother Theresa\", Service of Reanimation and Anesthesia, 4 University Hospital Center \"Mother Theresa\", SID Background: Although Tetanus is currently a relatively rare infectious disease it remains a high mortality disease (20-30%) with high management costs."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3182","span":{"begin":233,"end":243},"obj":"Disease"},{"id":"T3183","span":{"begin":412,"end":419},"obj":"Disease"},{"id":"T3184","span":{"begin":451,"end":469},"obj":"Disease"},{"id":"T3150","span":{"begin":233,"end":243},"obj":"Disease"},{"id":"T50752","span":{"begin":412,"end":419},"obj":"Disease"},{"id":"T91518","span":{"begin":451,"end":469},"obj":"Disease"}],"attributes":[{"id":"A3182","pred":"mondo_id","subj":"T3182","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A3183","pred":"mondo_id","subj":"T3183","obj":"http://purl.obolibrary.org/obo/MONDO_0005526"},{"id":"A3184","pred":"mondo_id","subj":"T3184","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A47973","pred":"mondo_id","subj":"T3150","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A38721","pred":"mondo_id","subj":"T50752","obj":"http://purl.obolibrary.org/obo/MONDO_0005526"},{"id":"A41653","pred":"mondo_id","subj":"T91518","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Besides, doxycycline therapy showed non-inferior to metronidazole or vancomycin therapy, according to body weight loss in mice with CDAD (doxycycline vs. metronidazole: 1.11 ± 0.56 kg vs. Hospital Center \"Mother Theresa\", Service of Infectious Diseases, 3 University Hospital Center \"Mother Theresa\", Service of Reanimation and Anesthesia, 4 University Hospital Center \"Mother Theresa\", SID Background: Although Tetanus is currently a relatively rare infectious disease it remains a high mortality disease (20-30%) with high management costs."}